Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Role of fragile X mental retardation protein in chronic pain. Molecular pain Mei, X. n., Yang, Y. n., Zhao, J. n., Wang, Y. n., Chen, Q. n., Qian, X. n., Li, X. n., Feng, Z. n. ; 16: 1744806920928619

Abstract

Chronic pain has detrimental effects on one's quality of life. However, its treatment options are very limited, and its underlying pathogenesis remains unclear. Recent research has suggested that fragile X mental retardation protein is involved in the development of chronic pain, making it a potential target for prevention and treatment. The current review of literature will examine the function of fragile X mental retardation protein and its associated pathways, through which we hope to gain insight into how fragile X mental retardation protein may contribute to nociceptive sensitization and chronic pain.

View details for DOI 10.1177/1744806920928619

View details for PubMedID 32496847